Ambion launches first SARS control
RNA specialist Ambion has introduced what it claims is the first
commercially available positive control for use in the detection of
the SARS virus.
Plant compounds for cancer control
MolecularNature has forged a drug discovery partnership with Zetiq
Technologies that has already yielded a number of novel cancer
ALA LabFusion springs from ISLAR ashes
This year's ISLAR meeting - the last ever to be held - will be
replaced in 2004 by a new Association of Laboratory Automation
conference called LabFusion.
Karo Bio cuts losses as R&D progresses
Swedish drug discovery company Karo Bio has trimmed its losses down
to SEK18.1 million in the second quarter of 2003 from SEK79.7
million a year earlier.
EU states taken to ECoJ over biotech
European Commission refers eight EU member states to the European
Court of Justice over their alleged failure to implement legal
protection of biotech inventions.
Amersham extends CyDye fluor range
Amersham Biosciences has added to its range of CyDye mono-reactive
fluor dyes with two products used for labelling proteins or
antibodies in protein array experiments.
4SC and Esteve extend CNS project
A pilot project aimed at identifying new drug candidates for
central nervous system disorders, initiated by Germany's 4SC and
Spain's Esteve, has grown into a full-blown collaboration between
Swedish BioTech Forum planned for November
The Karolinska Institute, together with the Swedish academy of
pharmaceutical sciences, is organising BioTech Forum 2003, to take
place from 26 to 28 November in Stockholm, Sweden.
Expressionist paints picture of cancer genetics
Genedata's Expressionist software is to be used in a cancer
research effort in Singapore aimed at developing clinical
diagnostics and identifying novel drug targets.
SARS yields secrets… and drug targets
A team of scientists studying severe acute respiratory syndrome
has, for the first time, described how the coronavirus (SARS CoV)
manufactures several of the materials required for viral
IBC event promises low down on drug design
IBC is holding its 3rd international conference on Small Molecule
& Protein Structure-Based Drug Discovery by Design on 8-10
October 2003 in San Diego.
Roche escapes Igen damages, but loses ECL rights
A US appeals court has reversed an earlier decision to make
Switzerland's Roche pay almost $500 million in damages to Igen in a
dispute over a technology used in clinical diagnostics and
Symphogen strengthens Ab patent position
Danish biotech company Symphogen has obtained a European patent on
its Symphage technology for the development of antibody-based
drugs. Clinical trials of the product candidate are due to start in
Applied Bio launches rat gene expression assays
A series of pre-formulated rat gene expression assays developed by
Applied Biosystems could provide a short cut to testing
toxicological responses to chemical compounds.
GSK settles Augmentin dispute with Novartis
Novartis has agreed to pay GlaxoSmithKline a royalty on sales of a
generic version of GSK's antibiotic Augmentin
(amoxicillin/clavulanate) sold in the USA as AmoxC.